BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 20060602)

  • 1. Effects of brevetoxin exposure on the immune system of loggerhead sea turtles.
    Walsh CJ; Leggett SR; Carter BJ; Colle C
    Aquat Toxicol; 2010 May; 97(4):293-303. PubMed ID: 20060602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal transfer and sublethal immune system effects of brevetoxin exposure in nesting loggerhead sea turtles (Caretta caretta) from western Florida.
    Perrault JR; Bauman KD; Greenan TM; Blum PC; Henry MS; Walsh CJ
    Aquat Toxicol; 2016 Nov; 180():131-140. PubMed ID: 27716578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune function in Trachemys scripta following exposure to a predominant brevetoxin congener, PbTx-3, as a model for potential health impacts for sea turtles naturally exposed to brevetoxins.
    Walsh CJ; Cocilova C; Restivo J; Flewelling L; Milton S
    Ecotoxicology; 2019 Nov; 28(9):1085-1104. PubMed ID: 31559558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of brevetoxin (PbTx-3) exposure in neurons of the anoxia-tolerant freshwater turtle (Trachemys scripta).
    Cocilova CC; Milton SL
    Aquat Toxicol; 2016 Nov; 180():115-122. PubMed ID: 27697698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue uptake, distribution and excretion of brevetoxin-3 after oral and intratracheal exposure in the freshwater turtle Trachemys scripta and the diamondback terrapin Malaclemys terrapin.
    Cocilova CC; Flewelling LJ; Bossart GD; Granholm AA; Milton SL
    Aquat Toxicol; 2017 Jun; 187():29-37. PubMed ID: 28363127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential effects of brevetoxins and toxic elements on various health variables in Kemp's ridley (Lepidochelys kempii) and green (Chelonia mydas) sea turtles after a red tide bloom event.
    Perrault JR; Stacy NI; Lehner AF; Mott CR; Hirsch S; Gorham JC; Buchweitz JP; Bresette MJ; Walsh CJ
    Sci Total Environ; 2017 Dec; 605-606():967-979. PubMed ID: 28693110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dehydration as an effective treatment for brevetoxicosis in loggerhead sea turtles (Caretta caretta).
    Manire CA; Anderson ET; Byrd L; Fauquier DA
    J Zoo Wildl Med; 2013 Jun; 44(2):447-52. PubMed ID: 23805564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sublethal red tide toxin exposure in free-ranging manatees (Trichechus manatus) affects the immune system through reduced lymphocyte proliferation responses, inflammation, and oxidative stress.
    Walsh CJ; Butawan M; Yordy J; Ball R; Flewelling L; de Wit M; Bonde RK
    Aquat Toxicol; 2015 Apr; 161():73-84. PubMed ID: 25678466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brevetoxin exposure in sea turtles in south Texas (USA) during Karenia brevis red tide.
    Walker JS; Shaver DJ; Stacy BA; Flewelling LJ; Broadwater MH; Wang Z
    Dis Aquat Organ; 2018 Jan; 127(2):145-150. PubMed ID: 29384484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of intravenous lipid emulsion therapy as a novel treatment for brevetoxicosis in sea turtles.
    Perrault JR; Barron HW; Malinowski CR; Milton SL; Manire CA
    Sci Rep; 2021 Dec; 11(1):24162. PubMed ID: 34921188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brevetoxin in blood, biological fluids, and tissues of sea turtles naturally exposed to Karenia brevis blooms in central west Florida.
    Fauquier DA; Flewelling LJ; Maucher J; Manire CA; Socha V; Kinsel MJ; Stacy BA; Henry M; Gannon J; Ramsdell JS; Landsberg JH
    J Zoo Wildl Med; 2013 Jun; 44(2):364-75. PubMed ID: 23805555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. INTRAVENOUS LIPID EMULSION TREATMENT REDUCES SYMPTOMS OF BREVETOXICOSIS IN TURTLES (
    Cocilova CC; Flewelling LJ; Granholm AA; Manire CA; Milton SL
    J Zoo Wildl Med; 2019 Mar; 50(1):33-44. PubMed ID: 31120660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurological disease in wild loggerhead sea turtles Caretta caretta.
    Jacobson ER; Homer BL; Stacy BA; Greiner EC; Szabo NJ; Chrisman CL; Origgi F; Coberley S; Foley AM; Landsberg JH; Flewelling L; Ewing RY; Moretti R; Schaf S; Rose C; Mader DR; Harman GR; Manire CA; Mettee NS; Mizisin AP; Shelton GD
    Dis Aquat Organ; 2006 Jun; 70(1-2):139-54. PubMed ID: 16875401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing Karenia brevis red tide as a mortality factor of sea turtles in Florida, USA.
    Foley AM; Stacy BA; Schueller P; Flewelling LJ; Schroeder B; Minch K; Fauquier DA; Foote JJ; Manire CA; Atwood KE; Granholm AA; Landsberg JH
    Dis Aquat Organ; 2019 Jan; 132(2):109-124. PubMed ID: 30628577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extraction and analysis of lipophilic brevetoxins from the red tide dinoflagellate Karenia brevis.
    Twiner MJ; Bottein Dechraoui MY; Wang Z; Mikulski CM; Henry MS; Pierce RH; Doucette GJ
    Anal Biochem; 2007 Oct; 369(1):128-35. PubMed ID: 17662954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fate and distribution of brevetoxin (PbTx) following lysis of Karenia brevis by algicidal bacteria, including analysis of open A-ring derivatives.
    Roth PB; Twiner MJ; Wang Z; Bottein Dechraoui MY; Doucette GJ
    Toxicon; 2007 Dec; 50(8):1175-91. PubMed ID: 17905402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brevetoxin (PbTx-2) influences the redox status and NPQ of Karenia brevis by way of thioredoxin reductase.
    Chen W; Colon R; Louda JW; Del Rey FR; Durham M; Rein KS
    Harmful Algae; 2018 Jan; 71():29-39. PubMed ID: 29306394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complex behavior of marine animal tissue extracts in the competitive binding assay of brevetoxins with rat brain synaptosomes.
    Whitney PL; Delgado JA; Baden DG
    Nat Toxins; 1997; 5(5):193-200. PubMed ID: 9496378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitogen-induced lymphocyte proliferation in loggerhead sea turtles: comparison of methods and effects of gender, plasma testosterone concentration, and body condition on immunity.
    Keller JM; McClellan-Green PD; Lee AM; Arendt MD; Maier PP; Segars AL; Whitaker JD; Keil DE; Peden-Adams MM
    Vet Immunol Immunopathol; 2005 Feb; 103(3-4):269-81. PubMed ID: 15621312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brevetoxin metabolism and elimination in the Eastern oyster (Crassostrea virginica) after controlled exposures to Karenia brevis.
    Plakas SM; Wang Z; El Said KR; Jester EL; Granade HR; Flewelling L; Scott P; Dickey RW
    Toxicon; 2004 Nov; 44(6):677-85. PubMed ID: 15501294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.